MatriSys Bioscience, Inc. logo — Harnessing beneficial bacteria to treat chronic inflammatory...

MatriSys Bioscience, Inc.

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.

Founded 2015 United States La Jolla, United States 6 employees Convertible Note Total: $4.50M Biopharma, Biotechnology +2

General Information

Company Name MatriSys Bioscience, Inc.
Founded Year 2015
Location United States La Jolla, United States
Founders / Decision Makers
Team member
Employees 6
Industries Biopharma, Biotechnology, Health Care +1
Funding Stage Convertible Note
Social

BounceWatch is an independent company data service, not affiliated with MatriSys Bioscience, Inc.. To contact MatriSys Bioscience, Inc., visit matrisysbio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does MatriSys Bioscience, Inc. compare?

A PDF of MatriSys Bioscience, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting MatriSys Bioscience, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About MatriSys Bioscience, Inc.

MatriSys Bioscience, Inc. is a clinical stage Specialty Biopharmaceutical Company that focuses on harnessing beneficial bacteria to treat chronic inflammatory skin conditions. The company is targeting the $142 Billion WW dermatology and skin care market by developing therapies for top skin conditions such as Atopic Dermatitis, Rosacea, Psoriasis, Acne, and Skin Infections, which collectively affect over 230 million patients. This represents a substantial $12.9 Billion Rx market and a $121 Billion skin care market. MatriSys Bio’s approach involves rebalancing the natural skin microbiome using microbial therapies, specifically targeting "Bad Bugs" with "Good Bugs." The company's lead microbiome Phase I/II clinical program, addressing the Atopic Dermatitis market, is particularly promising as it targets 15 M US patients and 132 M worldwide. This program is NIH funded and protected with an exclusive license from UCSD. The recent $3.00MConvertible Note investment on 11 March 2021 from Tech Coast Angels and Primer Capital highlights the confidence of prominent investors in MatriSys Bioscience's potential to revolutionize the dermatology and skin care market. With a strong scientific foundation, significant market potential, and strategic partnerships, MatriSys Bioscience, Inc. is positioned as an innovative player in the biopharma and biotechnology space.

Business keywords: Specialty Biopharmaceutical Company, Dermatology, Skin care, Microbiome Therapies, Atopic Dermatitis, Rosacea, Psoriasis, Acne, Skin Infections, Live Biotherapeutic Products, Biopharmaceutical product development, Cosmeceutics, Clinical Stage Company, NIH funded, IP protection

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Convertible Note $3.00M 2
Tech Coast Angels, Primer Capital
11 Mar 2021
Venture Round Undisclosed 2
Tech Coast Angels, Mesa Verde Venture Partners
01 Oct 2019
Seed Round Undisclosed 2
Baker & Eastlack Ventures, Primer Capital
08 Oct 2018
Convertible Note $1.50M 1
Tech Coast Angels
05 Jan 2017

MatriSys Bioscience, Inc. Alternatives & Competitors

View All Alternatives
MatriSys Bioscience, Inc. vs
Azitra Inc
Azitra Inc United States

Harnessing the microbiome to treat skin disease.

Post-IPO Equity
12 employees
Biotechnology, Consumer Goods
MatriSys Bioscience, Inc. vs

Expert care for your skin, from acne to anti-aging rejuvenation.

11 employees
Biotechnology, Health Care
MatriSys Bioscience, Inc. vs

Realm Therapeutics (AIM: RLM) is a clinical-stage biopharmaceutical company focused on developing no...

Post-IPO Equity
2 employees
Biotechnology, Pharmaceutical

FAQ About MatriSys Bioscience, Inc.

Harnessing beneficial bacteria to treat chronic inflammatory skin conditions.
MatriSys Bioscience, Inc. was founded in 2015.
MatriSys Bioscience, Inc. is headquartered in La Jolla, United States.
MatriSys Bioscience, Inc. operates in Biopharma, Biotechnology, Health Care and Pharmaceutical. Its work centres on Specialty Biopharmaceutical Company, Dermatology, Skin care and Microbiome Therapies.
MatriSys Bioscience, Inc. has approximately 6 employees.
MatriSys Bioscience, Inc. has completed 4 funding rounds, raising a total of $4.50M. The latest funding stage is Convertible Note.
Top alternatives and competitors to MatriSys Bioscience, Inc. include Azitra Inc, Dermatology & Skin Surgery Specialists, Realm Therapeutics, Inc., Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), VYNE Therapeutics Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MatriSys Bioscience, Inc. and Azitra Inc are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for MatriSys Bioscience, Inc., https://bouncewatch.com/company/matrisys-bioscience-inc, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes